Completed NA INTERVENTIONAL NCT01020617

The Effect of Probiotics on Low-grade Inflammation, Microbiota and Risk Factors for Metabolic Syndrome in Obese Children

Association Between the Diet, the Composition of Microbiota of the Intestinal Tract, Human Health and Well-being

Sponsor: Danisco

Conditions Inflammation Metabolic Syndrome Obesity

Interventions Ls-33

Updated 5 times since 2017 Last updated: Jan 18, 2011 Started: Apr 30, 2009 Primary completion: Aug 31, 2010 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01020617, this NA trial focuses on Inflammation and Metabolic Syndrome and remains completed. Sponsored by Danisco, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danisco
The Danish Medical Research Council
University of Copenhagen

Data source: University of Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frederiksberg, Denmark